ALPINE IMMUNE SCIENCES, INC. Operating Income
ALPINE IMMUNE SCIENCES, INC. reported Operating Income of -$22.70 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2024-05-09
- ALPINE IMMUNE SCIENCES, INC. operating income (loss) for the quarter ending 2024-03-31 was -$22.70M.
- ALPINE IMMUNE SCIENCES, INC. operating income (loss) for the quarter ending 2023-12-31 was $1.55M.
- ALPINE IMMUNE SCIENCES, INC. operating income (loss) for the quarter ending 2023-09-30 was -$14.55M.
- ALPINE IMMUNE SCIENCES, INC. operating income (loss) for the quarter ending 2023-06-30 was -$15.65M.
- ALPINE IMMUNE SCIENCES, INC. operating income (loss) for fiscal 2023 was -$44.25M.
- ALPINE IMMUNE SCIENCES, INC. operating income (loss) for fiscal 2022 was -$58.15M.
- ALPINE IMMUNE SCIENCES, INC. operating income (loss) for fiscal 2021 was -$49.86M.
- ALPINE IMMUNE SCIENCES, INC. operating income (loss) for fiscal 2020 was -$28.75M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | -$22.70M 10-Q · filed 2024-05-09 | -$21.15M derived: sum of 2 quarters · filed 2024-05-09 | -$35.70M derived: sum of 3 quarters · filed 2024-05-09 | -$51.35M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2023-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | -$13.00M derived: sum of 2 quarters · filed 2024-03-20 | -$28.66M derived: sum of 3 quarters · filed 2024-03-20 | -$44.25M 10-K · filed 2024-03-20 | ||||
| 2023-09-30 | -$14.55M 10-Q · filed 2023-11-14 | -$30.20M derived: sum of 2 quarters · filed 2023-11-14 | -$45.80M 10-Q · filed 2023-11-14 | -$66.17M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2023-06-30 | -$15.65M 10-Q · filed 2023-08-14 | -$31.25M 10-Q · filed 2023-08-14 | -$51.62M derived: sum of 3 quarters · filed 2024-05-09 | -$65.45M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2023-03-31 | -$15.59M 10-Q · filed 2024-05-09 | -$35.96M derived: sum of 2 quarters · filed 2024-05-09 | -$49.79M derived: sum of 3 quarters · filed 2024-05-09 | -$66.28M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | -$20.37M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | -$34.20M derived: sum of 2 quarters · filed 2024-03-20 | -$50.69M derived: sum of 3 quarters · filed 2024-03-20 | -$58.15M 10-K · filed 2024-03-20 | ||||
| 2022-09-30 | -$13.83M 10-Q · filed 2023-11-14 | -$30.32M derived: sum of 2 quarters · filed 2023-11-14 | -$37.78M 10-Q · filed 2023-11-14 | -$53.15M derived: sum of 4 quarters · filed 2024-03-20 | ||||
| 2022-06-30 | -$16.49M 10-Q · filed 2023-08-14 | -$23.95M 10-Q · filed 2023-08-14 | -$39.32M derived: sum of 3 quarters · filed 2024-03-20 | -$52.59M derived: sum of 4 quarters · filed 2024-03-20 | ||||
| 2022-03-31 | -$7.46M 10-Q · filed 2023-05-11 | -$22.83M derived: sum of 2 quarters · filed 2024-03-20 | -$36.10M derived: sum of 3 quarters · filed 2024-03-20 | -$46.83M derived: sum of 4 quarters · filed 2024-03-20 | ||||
| 2021-12-31 | -$15.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | -$28.64M derived: sum of 2 quarters · filed 2024-03-20 | -$39.37M derived: sum of 3 quarters · filed 2024-03-20 | -$49.86M 10-K · filed 2024-03-20 | ||||
| 2021-09-30 | -$13.26M 10-Q · filed 2022-11-14 | -$23.99M derived: sum of 2 quarters · filed 2022-11-14 | -$34.48M 10-Q · filed 2022-11-14 | -$40.94M derived: sum of 4 quarters · filed 2023-03-23 | ||||
| 2021-06-30 | -$10.73M 10-Q · filed 2022-08-11 | -$21.22M 10-Q · filed 2022-08-11 | -$27.68M derived: sum of 3 quarters · filed 2023-03-23 | -$34.65M derived: sum of 4 quarters · filed 2023-03-23 | ||||
| 2021-03-31 | -$10.49M 10-Q · filed 2022-05-12 | -$16.95M derived: sum of 2 quarters · filed 2023-03-23 | -$23.92M derived: sum of 3 quarters · filed 2023-03-23 | -$33.67M derived: sum of 4 quarters · filed 2023-03-23 | ||||
| 2020-12-31 | -$6.46M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$13.43M derived: sum of 2 quarters · filed 2023-03-23 | -$23.18M derived: sum of 3 quarters · filed 2023-03-23 | -$28.75M 10-K · filed 2023-03-23 | ||||
| 2020-09-30 | -$6.97M 10-Q · filed 2021-11-10 | -$16.72M derived: sum of 2 quarters · filed 2021-11-10 | -$22.29M 10-Q · filed 2021-11-10 | -$29.30M derived: sum of 4 quarters · filed 2022-03-17 | ||||
| 2020-06-30 | -$9.75M 10-Q · filed 2021-08-10 | -$15.32M 10-Q · filed 2021-08-10 | -$22.33M derived: sum of 3 quarters · filed 2022-03-17 | -$34.04M derived: sum of 4 quarters · filed 2022-03-17 | ||||
| 2020-03-31 | -$5.57M 10-Q · filed 2021-05-13 | -$12.58M derived: sum of 2 quarters · filed 2022-03-17 | -$24.29M derived: sum of 3 quarters · filed 2022-03-17 | -$36.44M derived: sum of 4 quarters · filed 2022-03-17 | ||||
| 2019-12-31 | -$7.02M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$18.73M derived: sum of 2 quarters · filed 2022-03-17 | -$30.88M derived: sum of 3 quarters · filed 2022-03-17 | -$43.57M 10-K · filed 2022-03-17 | ||||
| 2019-09-30 | -$11.71M 10-Q · filed 2020-11-12 | -$23.86M derived: sum of 2 quarters · filed 2020-11-12 | -$36.56M 10-Q · filed 2020-11-12 | -$48.00M derived: sum of 4 quarters · filed 2021-03-18 | ||||
| 2019-06-30 | -$12.15M 10-Q · filed 2020-08-11 | -$24.85M 10-Q · filed 2020-08-11 | -$36.29M derived: sum of 3 quarters · filed 2021-03-18 | -$48.68M derived: sum of 4 quarters · filed 2021-03-18 | ||||
| 2019-03-31 | -$12.70M 10-Q · filed 2020-05-14 | -$24.14M derived: sum of 2 quarters · filed 2021-03-18 | -$36.53M derived: sum of 3 quarters · filed 2021-03-18 | -$44.94M derived: sum of 4 quarters · filed 2021-03-18 | ||||
| 2018-12-31 | -$11.45M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$23.83M derived: sum of 2 quarters · filed 2021-03-18 | -$32.24M derived: sum of 3 quarters · filed 2021-03-18 | -$37.83M 10-K · filed 2021-03-18 | ||||
| 2018-09-30 | -$12.39M 10-Q · filed 2019-11-14 | -$20.80M derived: sum of 2 quarters · filed 2019-11-14 | -$26.39M 10-Q · filed 2019-11-14 | -$31.17M derived: sum of 4 quarters · filed 2020-03-30 | ||||
| 2018-06-30 | -$8.41M 10-Q · filed 2019-08-13 | -$14.00M 10-Q · filed 2019-08-13 | -$18.79M derived: sum of 3 quarters · filed 2020-03-30 | -$23.34M derived: sum of 4 quarters · filed 2020-03-30 | ||||
| 2018-03-31 | -$5.58M 10-Q · filed 2019-05-09 | -$10.37M derived: sum of 2 quarters · filed 2020-03-30 | -$14.93M derived: sum of 3 quarters · filed 2020-03-30 | -$18.57M derived: sum of 4 quarters · filed 2020-03-30 | ||||
| 2017-12-31 | -$4.79M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$9.34M derived: sum of 2 quarters · filed 2020-03-30 | -$12.98M derived: sum of 3 quarters · filed 2020-03-30 | -$14.97M 10-K · filed 2020-03-30 | ||||
| 2017-09-30 | -$4.55M 10-Q · filed 2018-11-08 | -$8.19M derived: sum of 2 quarters · filed 2018-11-08 | -$10.19M 10-Q · filed 2018-11-08 | -$18.01M derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | -$3.64M 10-Q · filed 2018-08-09 | -$3.81M 10-Q · filed 2017-07-21 | -$5.63M 10-Q · filed 2018-08-09 | -$12.84M 10-Q · filed 2017-07-21 | -$13.46M derived: sum of 3 quarters · filed 2018-08-09 | -$13.84M derived: sum of 4 quarters · filed 2018-08-09 | ||
| 2017-03-31 | -$1.99M 10-Q · filed 2018-05-14 | -$9.03M 10-Q · filed 2017-05-02 | -$9.82M derived: sum of 2 quarters · filed 2018-05-14 | -$10.20M derived: sum of 3 quarters · filed 2018-05-14 | -$18.80M derived: sum of 4 quarters · filed 2018-05-14 | |||
| 2016-12-31 | -$7.82M 10-K · filed 2017-02-13 | -$8.21M derived: sum of 2 quarters · filed 2017-11-14 | -$16.80M derived: sum of 3 quarters · filed 2017-11-14 | -$1.19M 10-K · filed 2019-03-18 | -$31.90M 10-K · filed 2017-02-13 | |||
| 2016-09-30 | -$381.00K 10-Q · filed 2017-11-14 | -$7.55M 10-Q · filed 2016-11-07 | -$8.98M derived: sum of 2 quarters · filed 2017-11-14 | -$201.00K 10-Q · filed 2017-11-14 | -$24.08M 10-Q · filed 2016-11-07 | -$23.54M derived: sum of 4 quarters · filed 2017-11-14 | ||
| 2016-06-30 | -$8.60M 10-Q · filed 2017-07-21 | -$16.53M 10-Q · filed 2017-07-21 | -$23.16M derived: sum of 3 quarters · filed 2017-07-21 | -$29.26M derived: sum of 4 quarters · filed 2017-07-21 | ||||
| 2016-03-31 | -$7.93M 10-Q · filed 2017-05-02 | -$14.56M derived: sum of 2 quarters · filed 2017-05-02 | -$20.66M derived: sum of 3 quarters · filed 2017-05-02 | -$26.52M derived: sum of 4 quarters · filed 2017-05-02 | ||||
| 2015-12-31 | -$6.63M 10-K · filed 2017-02-13 | -$12.73M derived: sum of 2 quarters · filed 2017-02-13 | -$18.58M derived: sum of 3 quarters · filed 2017-02-13 | -$371.00K 10-K · filed 2018-03-28 | -$22.90M 10-K · filed 2016-03-08 | |||
| 2015-09-30 | -$6.10M 10-K · filed 2017-02-13 | -$11.95M derived: sum of 2 quarters · filed 2017-02-13 | -$16.27M 10-Q · filed 2016-11-07 | -$19.75M derived: sum of 4 quarters · filed 2017-02-13 | ||||
| 2015-06-30 | -$5.85M 10-K · filed 2017-02-13 | -$10.17M 10-Q · filed 2016-08-02 | -$13.65M derived: sum of 3 quarters · filed 2017-02-13 | -$16.31M derived: sum of 4 quarters · filed 2017-02-13 | ||||
| 2015-03-31 | -$4.32M 10-K · filed 2017-02-13 | -$7.80M derived: sum of 2 quarters · filed 2017-02-13 | -$10.46M derived: sum of 3 quarters · filed 2017-02-13 | -$14.41M derived: sum of 4 quarters · filed 2017-02-13 | ||||
| 2014-12-31 | -$3.49M 10-K · filed 2016-03-08 | -$6.14M derived: sum of 2 quarters · filed 2016-03-08 | -$10.10M derived: sum of 3 quarters · filed 2016-03-08 | -$14.49M 10-K · filed 2017-02-13 | ||||
| 2014-09-30 | -$2.65M 10-K · filed 2016-03-08 | -$6.61M derived: sum of 2 quarters · filed 2016-03-08 | -$11.00M 10-Q · filed 2015-11-03 | |||||
| 2014-06-30 | -$3.96M 10-K · filed 2016-03-08 | -$8.35M 10-Q · filed 2015-08-04 | ||||||
| 2014-03-31 | -$4.39M 10-K · filed 2016-03-08 | |||||||
| 2013-12-31 | -$15.28M 10-K · filed 2016-03-08 |